Sensitivity and specificity of an operon immunochromatographic test in serum and whole-blood samples for the diagnosis of Trypanosoma cruzi infection in Spain, an area of nonendemicity

Clinical and Vaccine Immunology

Volumn 19, Issue 9, 2012, Pages 1353-1359

  Flores Chavez, María ^a   Cruz, Israel ^a   Nieto, Javier ^a   Gárate, Teresa ^a   Navarro, Miriam ^b   Pérez Ayala, Ana ^b   López Vélez, Rogelio ^b   Cañavate, Carmen ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PARASITE ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CHAGAS DISEASE; CHILD; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC TEST ACCURACY STUDY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALARIA; MALE; OPERON; PARASITEMIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROLOGY; TRYPANOSOMA CRUZI; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, PROTOZOAN; CHAGAS DISEASE; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOCHROMATOGRAPHY; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREGNANCY; SENSITIVITY AND SPECIFICITY; SPAIN; TRYPANOSOMA CRUZI; YOUNG ADULT;

EID: 84865978816     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00227-12     Document Type: Article

References (43)

1. Abalo M, et al. 2007. Tracing of one year of Chagas screening at the Centro de Transfusion de Galicia (C.T.G.). Concerning a positive blood donor, P-235. Vox Sang. 93(Suppl 1):140.
2. Reference deleted.
3. Camargo ME. 1966. Fluorescent antibody test for the serodiagnosis of American trypanosomiasis. Technical modification employing preserved culture forms of Trypanosoma cruzi in a slide test. Rev. Inst. Med. Trop. Sao Paulo 8:227-235.
4. Chappuis F, et al. 2010. Validation of a rapid immunochromatographic assay for diagnosis of Trypanosoma cruzi infection among Latin-American migrants in Geneva, Switzerland. J. Clin. Microbiol. 48:2948-2952.
5. Chippaux JP, Postigo JR, Santalla JA, Schneider D, Brutus L. 2008. Epidemiological evaluation of Chagas disease in a rural area of southern Bolivia. Trans. R. Soc. Trop. Med. Hyg. 102:578-584.
6. Chippaux JP, et al. 2009. Sensitivity and specificity of Chagas Stat-Pak test in Bolivia. Trop. Med. Int. Health 14:732-735.
7. Consellería de Sanitat and Comunidad de Valencia. 2007. Regulación del control de las infecciones congénitas y perinatales en la Comunidat Valenciana. Circular 3/2007. Consellería de Sanitat and Comunidad de Valencia, Valencia, Spain. http://www.sp.san.gva.es /DgspPortal/docs/CIRCULAR-3-2007.pdf. Accessed 10 April 2012.
8. Dendukuri N, Bélisle P, Lawrence J. 2010. Bayes Latent Class Models version 1.4. Division of Clinical Epidemiology, McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada. http://www.medicine. mcgill.ca/epidemiology/Joseph/Bayesian-Software-Diagnostic -Testing.html.
9. Departament de Salut and Generalitat de Catalunya. 2010. Protocol for screening and diagnosing Chagas disease in pregnant Latin American women and their newborns. Departament de Salut and Generalitat de Catalunya, Barcelona, Spain. http://www20.gencat.cat/docs/canalsalut/Home%20Canal%20Salut/ Professionals/Temes-de-salut/Chagas/documents/Arxius/chagas-angles.pdf. Accessed 10 April 2012.
10. Flores-Chavez M, et al. 2010. Comparison of conventional and nonconventional serological tests for the diagnosis of imported Chagas disease in Spain. Enferm. Infecc. Microbiol. Clin. 28:284 -293. (In Spanish.)
11. Flores-Chavez M, et al. 2008. Fatal congenital Chagas' disease in a nonendemic area: a case report. Cases J. 1:302.
12. Flores-Chavez M, et al. 2008. Transfusional Chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. Clin. Infect. Dis. 46:e44-e47. (Pubitemid 351321569)
13. Fores R, et al. 2007. Chagas disease in a recipient of cord blood transplantation. Bone Marrow Transplant. 39:127-128. (Pubitemid 46085232)
14. Grupo de Trabajo de Chagas de la Comunidad Autónoma de Madrid. 2008. Recomendaciones para el control de la infección por Trypanosoma cruzi. Enfermedad de Chagas en Gestantes Latinoamericanas, Madrid, Spain. http://www.se -neonatal.es/Portals/0/Documento-Consenso-Chagas-2008.pdf. Accessed 10 April 2012.
15. Houghton RL, et al. 2009. Lateral flow immunoassay for diagnosis of Trypanosoma cruzi infection with high correlation to the radioimmunoprecipitation assay. Clin. Vaccine Immunol. 16:515-520.
16. Jackson Y, et al. 2009. Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Emerg. Infect. Dis. 15:601-603.
17. Ji MJ, et al. 2009. Evaluation of SD BIOLINE Chagas Ab rapid kit. Korean J. Lab. Med. 29:48-52. (In Korean.)
18. Lopez-Chejade P, et al. 2010. Utility of an immunochromatographic test for Chagas disease screening in primary healthcare. Enferm. Infecc. Microbiol. Clin. 28:169-171. (In Spanish.)
19. Luquetti AO, et al. 2003. Chagas' disease diagnosis: a multicentric evaluation of Chagas Stat-Pak, a rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruzi. Diagn. Microbiol. Infect. Dis. 46:265-271. (Pubitemid 37025763)
20. Luquetti AO, Rassi A. 2002. Perspectiva del uso de la serología (Ag naturales y otros) en la evaluación de la eficacia del tratamiento etiológico. 2do Simposio Internacional de E. de Chagas en Internet. http://www.fac.org.ar/fec/chagas2/llave/c003/luque.htm. Accessed 10 April 2012.
21. Machado-Coelho GL, Vitor RW, Chiari CA, Antunes CM. 1995. Validity of serology for American trypanosomiasis with eluates from filter paper. Mem. Inst. Oswaldo Cruz 90:59-64.
22. Mallimaci MC, et al. 2010. Early diagnosis of congenital Trypanosoma cruzi infection, using shed acute phase antigen, in Ushuaia, Tierra del Fuego, Argentina. Am. J. Trop. Med. Hyg. 82:55-59.
23. Ministerio de Sanidad y Consumo [Spain]. 2005. Real Decreto 1088/2005, de 16 de Septiembre, por el que se establecen los requisitos técnicos y condiciones mínimas de la hemodonación y de los centros y servicios de transfusión, BOE no.225, p 31288-31304. http://www.msc.es/ profesionales/saludPublica/medicinaTransfusional/legislacion/docs/RD-1088-2005. pdf. Accessed 10 April 2012.
24. Muñoz J, et al. 2009. Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clin. Infect. Dis. 48:1736-1740.
25. Muñoz J, Portus M, Corachan M, Fumado V, Gascon J. 2007. Congenital Trypanosoma cruzi infection in a non-endemic area. Trans. R. Soc. Trop. Med. Hyg. 101:1161-1162. (Pubitemid 47454411)
26. Muñoz J, et al. 2009. Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain). Acta Trop. 111:51-55.
27. Navarro M, et al. 2011. Targeted screening and health education for Chagas disease tailored to at-risk migrants in Spain, 2007 to 2010. Euro Surveill. 16(38):pii=19973.
28. Ozaeta S, Rezola AR, Ruiz M, Bejarano R, Ibarra A. 2008. Enfermedad de Chagas y donación, abstr S1-05, p 196. Boletín de la Sociedad Española de Transfusión Sanguínea y Terapia Celular, Especial Ponencias Congreso.
29. Perez de Pedro I, et al. 2008. Caso clínico de enfermedad de Chagas transfusional [comunicaciones orales]. Enf. Emerg. 10(Suppl 1):14-15.
30. Perez de Ayala A, Perez-Molina JA, Norman F, Lopez-Velez R. 2009. Chagasic cardiomyopathy in immigrants from Latin America to Spain. Emerg. Infect. Dis. 15:607-608.
31. Pirard M, et al. 2005. The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion 45:554-561.
32. Ponce C, et al. 2005. Validation of a rapid and reliable test for diagnosis of Chagas' disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central America. J. Clin. Microbiol. 43: 5065-5068. (Pubitemid 41484005)
33. Ramirez JD, et al. 2009. Evaluation of adult chronic Chagas' heart disease diagnosis by molecular and serological methods. J. Clin. Microbiol. 47: 3945-3951.
34. Rassi A, Jr, Rassi A, Marin-Neto JA. 2010. Chagas disease. Lancet 375: 1388-1402.
35. Riera C, et al. 2006. Congenital transmission of Trypanosoma cruzi in Europe (Spain): a case report. Am. J. Trop. Med. Hyg. 75:1078-1081. (Pubitemid 351627484)
36. Rodriguez-Guardado A, et al. 2009. Serological screening of Chagas disease in an immigrant population in Asturias, Spain proceeding from Chagas-endemic areas. Scand. J. Infect. Dis. 41:774-776.
37. Sanchez Negrette O, et al. 2008. Serological evaluation of specificantibody levels in patients treated for chronic Chagas' disease. Clin. Vaccine Immunol. 15:297-302.
38. Sosa-Estani S, et al. 2008. Use of a rapid test on umbilical cord blood to screen for Trypanosoma cruzi infection in pregnant women in Argentina, Bolivia, Honduras, and Mexico. Am. J. Trop. Med. Hyg. 79:755-759.
39. Verani JR, et al. 2009. Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infection. Am. J. Trop. Med. Hyg. 80:410-415.
40. Villalba R, et al. 1992. Acute Chagas' disease in a recipient of a bone marrow transplant in Spain: case report. Clin. Infect. Dis. 14:594-595.
41. WHO. 2002. Control of Chagas disease, p 1-124. WHO Press, Geneva, Switzerland.
42. WHO. 2010. Control and prevention of Chagas disease in Europe. WHO, Geneva, Switzerland. http://www.fac.org.ar/1/comites/chagas /Chagas-WHO- Technical%20Report-16-06-10.pdf. Accessed 10 April 2012.
43. WHO. 2010. Working to overcome the global impact of neglected tropical diseases: first WHO report on neglected tropical diseases. WHO, Geneva, Switzerland. http://whqlibdoc.who.int/publications/2010/9789241564090-eng.pdf. Accessed 10 June 2012.